Adalimumab Biosimilar Landscape Report Provides an Analysis of 35+ Companies along with Updated 45+ Marketed and Pipeline Drugs | DelveInsight
19 janv. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Adalimumab Biosimilar Landscape Report Provides an Analysis of 35+ Companies along with Updated 45+ Marketed and Pipeline Drugs | DelveInsight ...
Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025
18 janv. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Implantable Cardiac Monitors Market Expected To Rise By A CAGR Of 4.4% By 2025The steady growth of the Implantable Cardiac monitors (ICM) market...
Diabetic Peripheral Neuropathy Pipeline Assessment 2020: Therapeutic Analysis Report Featuring 20+ Companies & 15+ Drug Profiles
14 janv. 2021 18h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Diabetic Peripheral Neuropathy Pipeline Assessment 2020: Therapeutic Analysis Report Featuring 20+ Companies & 15+ Drug Profiles Diabetic...
Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020
13 janv. 2021 20h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Nonalcoholic Steatohepatitis Drug Pipeline Analysis Review, 2020 NASH Drug Pipeline Shows Promise as 95+ companies are working for...
Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
13 janv. 2021 18h30 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Multiple System Atrophy Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Multiple System Atrophy Clinical Trial Analysis...
Epidermolysis bullosa pipeline anticipated to offer several novel pipeline therapies in the next decade
12 janv. 2021 12h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Epidermolysis bullosa pipeline anticipated to offer several novel pipeline therapies in the next decade The Epidermolysis bullosa clinical...
Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight
05 janv. 2021 09h30 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Deep Brain Stimulation Devices Market Expected To Rise Significantly By 2025, Estimates DelveInsight DelveInsight predicts a favorable growth...
Non-Hodgkin's Lymphoma (NHL) Therapeutics Clinical Trial Analysis Report 2020
22 déc. 2020 07h38 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Non-Hodgkin's Lymphoma (NHL) Therapeutics Clinical Trial Analysis Report 2020 Major prominent players operating in the NHL therapeutics clinical...
Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
17 déc. 2020 11h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Glioblastoma Multiforme Clinical Trial Analysis...
Polycythemia Vera Pipeline Report presents an Updated Clinical Data of all the companies working in the Polycythemia Vera drug development scenario.
09 déc. 2020 08h20 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Polycythemia Vera Pipeline Report presents an Updated Clinical Data of all the companies working in the Polycythemia Vera drug development...